INT159523

From wiki-pain
Jump to: navigation, search
Context Info
Confidence 0.42
First Reported 2002
Last Reported 2009
Negated 0
Speculated 0
Reported most in Body
Documents 9
Total Number 9
Disease Relevance 2.10
Pain Relevance 2.91

This is a graph with borders and nodes. Maybe there is an Imagemap used so the nodes may be linking to some Pages.

Anatomy Link Frequency
tail skin 3
spinal cord 2
tail 2
neck 1
ECT (Homo sapiens)
Pain Link Frequency Relevance Heat
antinociception 176 100.00 Very High Very High Very High
Spinal cord 176 99.90 Very High Very High Very High
agonist 128 99.86 Very High Very High Very High
antidepressant 14 99.46 Very High Very High Very High
intrathecal 140 98.48 Very High Very High Very High
Antinociceptive 124 98.20 Very High Very High Very High
magnetoencephalography 2 98.14 Very High Very High Very High
imagery 32 97.88 Very High Very High Very High
anesthesia 5 90.68 High High
tail-flick 36 79.44 Quite High
Disease Link Frequency Relevance Heat
Schizophrenia 4 100.00 Very High Very High Very High
Catatonia 2 99.80 Very High Very High Very High
Cognitive Disorder 59 98.16 Very High Very High Very High
Depression 210 80.60 Quite High
Handedness 3 76.00 Quite High
Confusion 5 61.76 Quite High
Stress 1 51.72 Quite High
Nociception 52 50.00 Quite Low
Urological Neuroanatomy 6 48.40 Quite Low
Alcohol Addiction 12 38.80 Quite Low

Sentences Mentioned In

Key: Protein Mutation Event Anatomy Negation Speculation Pain term Disease term
Patients were scanned immediately after ECT (within 15 minutes), and T2 relaxation time changes are not expected to occur by then.
Positive_regulation (immediately) of Gene_expression (scanned) of ECT
1) Confidence 0.42 Published 2007 Journal Indian Journal of Psychiatry Section Body Doc Link PMC2902093 Disease Relevance 0.32 Pain Relevance 0.26
When ECT is provided to adolescents, the potential impact of such cognitive changes should be discussed with the patients and their parents or guardians in terms of implications for not only the patientÂ’s emotional functioning but cognitive functioning as well, particularly upon his or her academic performance.
Positive_regulation (When) of Gene_expression (provided) of ECT associated with cognitive disorder
2) Confidence 0.39 Published 2008 Journal Neuropsychiatric Disease and Treatment Section Body Doc Link PMC2526376 Disease Relevance 0.47 Pain Relevance 0.09
Of the 26 patients started on UB-RUL ECT, 12 (46%) experienced a lack of effectiveness and/or insufficient seizure induction and were thus switched to BL ECT; the 8 patients switched because of lack of effectiveness received a mean (SD) of 12.2 (2.9) treatments, whereas the 4 patients switched because of insufficient seizure induction received a mean (SD) of 11.3 (3.6) treatments.
Positive_regulation (induction) of Gene_expression (started) of ECT
3) Confidence 0.38 Published 2009 Journal J ECT Section Body Doc Link 19384251 Disease Relevance 0 Pain Relevance 0
Of those 21 ECT patients who were rejected, one patient did not give her consent to the study, eight patients received bifrontal (BF) ECT as a part of a preliminary study comparing the effects of BF and RUL ECT, five patients participated in the ongoing magnetoencephalography ECT study, two patients refused to discontinue the antidepressant medication, three patient received outpatient ECT, one patient received bitemporal (BT) ECT for schizophrenia, and one patient BT ECT for catatonia.
Positive_regulation (received) of Gene_expression (one) of ECT associated with magnetoencephalography, antidepressant, catatonia and schizophrenia
4) Confidence 0.38 Published 2002 Journal BMC Psychiatry Section Body Doc Link PMC65527 Disease Relevance 0.66 Pain Relevance 0.32
Of those 21 ECT patients who were rejected, one patient did not give her consent to the study, eight patients received bifrontal (BF) ECT as a part of a preliminary study comparing the effects of BF and RUL ECT, five patients participated in the ongoing magnetoencephalography ECT study, two patients refused to discontinue the antidepressant medication, three patient received outpatient ECT, one patient received bitemporal (BT) ECT for schizophrenia, and one patient BT ECT for catatonia.
Positive_regulation (patient) of Gene_expression (one) of ECT associated with magnetoencephalography, antidepressant, catatonia and schizophrenia
5) Confidence 0.38 Published 2002 Journal BMC Psychiatry Section Body Doc Link PMC65527 Disease Relevance 0.65 Pain Relevance 0.28
For example, a rise in tail thresholds [ECT (t)] after intrathecal drug, but not neck thresholds [ECT (n)], proves that the drug is confined in its actions to the caudal segments of the spinal cord for ECT antinociception and also any concurrent increase in TFL.
Positive_regulation (increase) of Gene_expression (antinociception) of ECT in tail associated with antinociception, spinal cord and intrathecal
6) Confidence 0.04 Published 2002 Journal BMC Pharmacol Section Body Doc Link PMC137595 Disease Relevance 0 Pain Relevance 0.56
These values were used to identify ECT neck data that showed no significant change following intrathecal agonist (within the 95% confidence intervals around the mean) and thus the corresponding ECT tail and TFL changes that could be ascribed to a spinal cord action of the intrathecal drug.
Positive_regulation (corresponding) of Gene_expression (tail) of ECT in spinal cord associated with agonist, spinal cord and intrathecal
7) Confidence 0.04 Published 2002 Journal BMC Pharmacol Section Body Doc Link PMC137595 Disease Relevance 0 Pain Relevance 0.32
Dose response curves for the antinociceptive effects of McN-A-343 (M1 agonist) and carbachol (non selective cholinergic agonist) were generated using ECT at neck and tail skin sites and TFL.
Positive_regulation (generated) of Gene_expression (using) of ECT in tail skin associated with agonist and antinociceptive
8) Confidence 0.04 Published 2002 Journal BMC Pharmacol Section Body Doc Link PMC137595 Disease Relevance 0 Pain Relevance 0.54
Dose response curves for the antinociceptive effects of McN-A-343 (M1 agonist) and carbachol (non selective cholinergic agonist) were generated using ECT at neck and tail skin sites and TFL.
Positive_regulation (generated) of in neck Gene_expression (using) of ECT in tail skin associated with agonist and antinociceptive
9) Confidence 0.01 Published 2002 Journal BMC Pharmacol Section Body Doc Link PMC137595 Disease Relevance 0 Pain Relevance 0.54

General Comments

This test has worked.

Personal tools
Namespaces

Variants
Actions
Navigation
Toolbox